olivLaw · European equity research
Remy Cointreau RCO.PA
France · Euronext Paris · ISIN FR0000130395 · Vertical: Listed companies from France
At the close of 05 Nov 2026, Remy Cointreau (RCO.PA) stock was 52.30 EUR (+1.06% on the day), with market capitalisation 2.7 bn EUR, P/E 34.9 on diluted EPS of 1.50 EUR over the last 12 months, dividend yield 2.16%, beta 0.69, 52-week range 34.88–52.30 EUR.
Data as of · Source: ESEF annual reports and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 64.2
- strong (55–70)
- Bollinger (20, 2)
- 43.23 – 55.48
- in the upper half of the band · %B 0.74 · band width 24.8%
- SMA 50 / 200
- 45.73 / 42.89
- uptrend (price > SMA50 > SMA200)
- MACD (12, 26, 9)
- 1.83 / 1.78
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | EURO STOXX 50 | vs EURO STOXX 50 | Vertical median | |
|---|---|---|---|---|
| 1 month | +26.1% | −0.6% | +26.8 pp | — |
| 3 months | +15.2% | −4.2% | +19.4 pp | — |
| 6 months | +28.2% | +4.3% | +23.9 pp | — |
| Year to date | +42.7% | +7.5% | +35.2 pp | — |
| 1 year | +21.5% | +9.9% | +11.5 pp | −6.8% |
| 3 years | −54.6% | +49.8% | −104.4 pp | −15.9% |
| 5 years | −70.6% | +42.8% | −113.4 pp | — |
Price returns, dividends excluded.
Quarterly results
ESEF annual reports carry no quarters: the results are annual (below).
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 100 percentile of its own 3-quarter history (min 18.4, median 24.5, max 25.8; quarters with earnings only).
Fiscal years
| Fiscal year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | 1.2 bn | 984.6 m | 935.3 m |
| Revenue YoY | unavailable | −17.5% | −5.0% |
| Net income | 184.8 m | 121.2 m | 78.7 m |
| Net income YoY | unavailable | −34.4% | −35.1% |
| Diluted EPS | 3.62 | 2.34 | 1.50 |
| Diluted EPS YoY | unavailable | −35.4% | −35.9% |
| net % | 15.5% | 12.3% | 8.4% |
| Free cash flow | unavailable | unavailable | unavailable |
Balance sheet & financial health
Fiscal year 2026 · 31 Mar 2026
- Cash
- 78.0 m EUR
- Financial debt
- unavailable EUR
- Net debt
- unavailable EUR
- Equity
- 1.9 bn EUR
- Total assets
- 3.5 bn EUR
- Debt / equity
- unavailable
- Current ratio
- 3.16x
- ROE
- 4.1%
- ROA
- 2.3%
- FCF margin
- unavailable
Financial statements (source on every figure)
Revenue and net income (EUR)
Margins
Income statement · EUR
| Line | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|
| Revenue | 1.2 bn | 984.6 m | 935.3 m | esef· 07 Jul 2026verified |
| Cost of revenue | 344.0 m | 289.8 m | 319.5 m | esef· 07 Jul 2026verified |
| Gross profit | 850.2 m | 694.8 m | 615.8 m | esef· 07 Jul 2026verified |
| Operating income | 291.6 m | 211.0 m | 151.5 m | esef· 07 Jul 2026verified |
| Income tax | 69.4 m | 48.2 m | 31.4 m | esef· 07 Jul 2026verified |
| Net income | 184.8 m | 121.2 m | 78.7 m | esef· 07 Jul 2026verified |
| Diluted EPS | 3.62 | 2.34 | 1.50 | esef· 07 Jul 2026verified |
| Weighted average diluted shares | 51.1 m | 51.8 m | 52.5 m | esef· 07 Jul 2026verified |
| Dividend per share | 3.01 | 1.50 | 1.13 | esef· 07 Jul 2026derived |
Balance sheet · EUR
| Line | 2024 | 2025 | 2026 | Source (latest year) |
|---|---|---|---|---|
| Cash | 93.0 m | 83.1 m | 78.0 m | esef· 07 Jul 2026verified |
| Receivables | 238.2 m | 187.5 m | 170.5 m | esef· 07 Jul 2026verified |
| Inventories | 2.0 bn | 2.1 bn | 2.2 bn | esef· 07 Jul 2026verified |
| Current assets | 2.3 bn | 2.4 bn | 2.4 bn | esef· 07 Jul 2026verified |
| Property, plant & equipment, net | 450.6 m | 464.4 m | 452.4 m | esef· 07 Jul 2026verified |
| Total assets | 3.4 bn | 3.4 bn | 3.5 bn | esef· 07 Jul 2026verified |
| Accounts payable | 676.3 m | 639.1 m | 656.0 m | esef· 07 Jul 2026verified |
| Current liabilities | 934.8 m | 865.0 m | 770.8 m | esef· 07 Jul 2026verified |
| Equity | 1.8 bn | 1.9 bn | 1.9 bn | esef· 07 Jul 2026verified |
| Shares outstanding at year end | 50.8 m | 51.4 m | 52.1 m | esef· 07 Jul 2026derived |
Cash flow · EUR
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
1 indicators that do not apply to the sector.
Valuation
olivLaw classification
- indicators available: 4 of at least 6
- score weight coverage: 27.1% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
05 Nov 2026Source: olivLaw, closing series
Market cap: 2.7 bn EUR
Key indicators
Coverage and freshness
Score by group
27% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 15.34 – 44.70 EUR.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (EUR per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · input data missing
- Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: P/E16.64 – 44.70 (Mid 25.70)20 companies used · median multiple 17.1x · quartiles 11.1x – 29.8x74SW.PA, ABEO.PA, AC.PA, ADP.PA, AF.PA, AI.PA, ALBON.PA, ALCIS.PA, ALCLA.PA, ALFER.PA, ALHEX.PA, ALO.PA, ALPWG.PA, ALSOG.PA, ANTIN.PA, ARAMI.PA, ATE.PA, AUB.PA, AURE.PA, BB.PA
- Dividend discount (DDM)15.34 – 20.92 (Mid 17.70)
Assumptions (illustrative, editorial)
- Risk-free rate
- 3.0%
- Equity risk premium
- 5.5%
- Beta (default)
- 1.00
- Cost of equity
- 8.5%
- Terminal growth
- 2.0%
Factor scorecard
Insufficient data
Minimum-evidence gate: indicators available: 4 of at least 6; score weight coverage: 27.1% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | 8.4% | 85 (vs peers) | 23% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | unavailable | unavailable | — |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 3.2x | 100 (on a fixed band) | 15% |
| P/E (TTM) · Valuation | 34.9x | 17 (vs peers) | 38% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | unavailable | unavailable | — |
| Shareholder yield (distributions) · Returns | 2.2% | 31 (on a fixed band) | 23% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partial100/100 · 1/3 factors with a value
- Growth· partialunavailable · 0/2 factors with a value
- Quality· partial85/100 · 1/3 factors with a value
- Returns· partial31/100 · 1/2 factors with a value
- Valuation· partial17/100 · 1/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
REMY COINTREAU (RCO.PA). Latest full fiscal year: 2026; data up to 2026-03-31.
Figures computed from the financial statements: revenue 935.3 m EUR in 2026; YoY growth -5.0%; net margin 8.4%; ROE 4.1%.
The estimated value range is 15.99–32.81 EUR per share (median of 2 methods, agreement: high); assumptions are illustrative. Against the central value of 21.70 EUR, the price of 52.30 EUR leaves a potential of -58.5% (value / price − 1) and a margin of safety of -141.0% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (indicators available: 4 of at least 6; score weight coverage: 27.1% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Net margin: 8.4%
- Current ratio: 3.2x
What contradicts it
- P/E (TTM): 34.9x
- The price is above the estimated value range
Not assessed (insufficient data or a ratio without meaning): ROIC, FCF conversion, Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, Interest coverage, EV/EBITDA, FCF yield, Payout ratio (FCF).
Versus the vertical median
Listed companies from France · same country · compared with 39 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| AI.PAL'air Liquide Societe Anonyme Pour L'etude Et L'exploitation Des Procedes Georges Claude | 109.3 bn | 33.2 | 12.9% | 12.2% | −2.0% | +26% / +32% |
| AC.PAAccor | 13.8 bn | 30.7 | 9.6% | 8.0% | +0.6% | +6% / +56% |
| ADP.PAAeroports De Paris | 11.7 bn | 34.1 | 7.8% | 5.6% | +12.1% | −7% / +4% |
| AKE.PAArkema | 7.1 bn | 115.4 | 0.9% | 0.7% | −5.0% | +12% / −37% |
| ALO.PAAlstom | 5.8 bn | 18.3 | 3.1% | 1.7% | +3.7% | −51% / −4% |
| AF.PAAir France - Klm | 4.3 bn | 13.6 | — | 1.0% | +4.8% | +20% / +9% |
| ATE.PAAlten | 3.1 bn | 29.5 | 4.8% | 2.6% | −1.1% | +33% / −29% |
| RCO.PARemy Cointreau | 2.7 bn | 34.9 | 4.1% | 8.4% | −5.0% | +32% / −52% |
| BB.PASociete Bic | 2.7 bn | 31.3 | 5.0% | 4.1% | −4.8% | +32% / +5% |
| ANTIN.PAAntin Infrastructure Partners | 1.4 bn | 13.0 | 21.9% | 36.6% | −8.1% | −24% / −35% |
| 74SW.PA74software | 792.7 m | 20.9 | 8.9% | 8.5% | +44.8% | −13% / +41% |
| AUB.PAAubay | 667.4 m | 17.8 | 13.6% | 6.3% | +11.3% | +3% / +45% |
| ASY.PAAssystem | 507.1 m | 69.9 | 2.5% | 1.1% | +7.4% | −19% / −18% |
| ATO.PAAtos Se | 483.0 m | — | -23,400.0% | -17.5% | −16.5% | −45% / −94% |
| ARAMI.PAAramis Group | 298.8 m | 15.0 | 10.0% | 0.8% | +6.3% | −33% / −16% |
| ARVEN.PAArverne Group | 246.1 m | — | -14.0% | -115.3% | +27.0% | +20% / −35% |
| BGO.PACompagnie Chargeurs Invest | 189.4 m | — | -8.6% | -5.7% | −2.9% | unavailable / unavailable |
| ALCIS.PACatering International & Services | 145.0 m | 28.4 | 9.3% | 1.9% | +5.8% | +39% / +107% |
| ALCGM.PACegedim | 144.6 m | — | -2.6% | -1.2% | +10.9% | −26% / −49% |
| ATEME.PAAteme | 144.0 m | 151.3 | 2.8% | 1.0% | +2.2% | +82% / +77% |
| ALHEX.PAHexaom | 144.0 m | 6.7 | 9.9% | 2.2% | +13.1% | −32% / +7% |
| ALBON.PACompagnie Lebon | 111.7 m | 16.5 | 4.2% | 8.8% | −17.9% | +6% / +8% |
| ALHYF.PALhyfe | 75.8 m | — | -33.4% | -570.5% | +287.2% | unavailable / unavailable |
| ALFER.PASergeferrari Group | 61.5 m | 11.5 | 5.1% | 1.5% | +7.4% | −33% / −27% |
| ABEO.PAAbeo | 60.8 m | 7.3 | 6.9% | 3.0% | +12.6% | −13% / −54% |
1- and 3-year price returns: for RCO.PA from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (EUR)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 28.15 Total return -45% · Per year -45% | 50.02 Total return -2% · Per year -2% | 75.68 Total return 47% · Per year 47% |
| 3 years | 22.35 Total return -53% · Per year -22% | 45.14 Total return -8% · Per year -3% | 75.68 Total return 52% · Per year 15% |
| 5 years | 17.75 Total return -60% · Per year -17% | 40.74 Total return -13% · Per year -3% | 75.68 Total return 57% · Per year 9% |
- Exit P/E± 11.28
- Net margin± 7.90
- Annual revenue growth± 7.13
- Annual dilution± 0.66
AI analysis
The qualitative analysis has not been written for this company yet.
Products, market & competition
The qualitative analysis has not been written for this company yet.
News & filings
In the press
- Remy Cointreau Beats Estimates on Strong China Cognac DemandBloomberg Markets · 28 Oct 2026 · EN
Annual reports (ESEF)
- Annual report 202607 Jul 2026
- Annual report 202607 Jul 2026
- Annual report 202501 Jul 2025
- Annual report 202401 Jul 2025
Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.